AMERICAN REBEL HOLDINGS INC (AREB)
NASDAQConsumer DiscretionaryApparel - Footwear & AccessoriesSnapshot 2026-09-04
$0.15-0.20%
Close 2026-09-04 · 1-day change
NASDAQConsumer DiscretionaryApparel - Footwear & AccessoriesSnapshot 2026-09-04
Warn: Primary pillar under pressure — Engage in M&A activities for strategic growth: 0 material M&A deals vs 2 required.
American Rebel Holdings is actively managing capital by issuing equity and raising loans totaling over $570,000. The company pursues M&A deals to drive growth, shown by multiple agreements in 2026. Despite losses, these moves could stabilize finances and improve market position.
The company is loss-making with volatile management and high risk. Equity dilution from over 1.7 million shares issued recently weakens shareholder value. Rising debt and regulatory issues may worsen financial health and stall recovery.
The market is selling off the stock sharply, reflecting concerns about losses and dilution. No clear consensus revenue or earnings growth is priced in, leaving uncertainty about future performance.
Breaks if: capital raised falls below $500,000 in next 4 quarters
Breaks if: fewer than two deals or deals under $300,000 in next 4 quarters
Pursue mergers and acquisitions to expand the company's strategic footprint and growth opportunities.
Breaks if: regulatory issues remain unresolved or worsen beyond current status
The company is focusing on addressing regulatory compliance issues, including delisting notices.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
AREB represents a speculative growth investment with a medium confidence level. The current thesis state is cautious, as the company is loss-making and has volatile management, which raises concerns about its future trajectory.
The market appears to price in a cheap valuation compared to peers, but there is a significant expectations gap. Investors seem to be aware of the company's challenges, as it is currently seen as justified despite its weak performance.
Fundamentals are likely to remain weak in the near term, as the company has recently reported a decline in momentum. Management's focus on converting backlog into revenue and managing capital allocation is ongoing, but results are mixed and not yet established.
The long-term thesis hinges on external factors like inflation trends and the performance of sector bellwethers. If key competitors continue to perform well, it could provide a tailwind for AREB, but any signs of weakness in those companies could negatively impact AREB's prospects.
In the next 1 to 3 years, AREB's performance will depend heavily on its ability to navigate sector challenges and execute on its management priorities. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The company entered a convertible note agreement with GS Capital. This supports its capital allocation strategy. There are no new threats to the thesis.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.